Drug
Fluorodeoxyglucose F18 clinical trials
Also written 18F-FDG and Fludeoxyglucose F18.
- studies test it
- 39
- open now
- 9
- in phase 3
- 3
- first study started
- 1997
Keep track of what changes. Save the Fluorodeoxyglucose F18 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
39 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 1997 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 5
- Phase 1
- 11
- Phase 2
- 9
- Phase 3
- 3
- Phase 4
- 1
- No phase
- 11
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 37
Stanford University (5) · Peking Union Medical College Hospital (3) · University of Washington (2) · M.D. Anderson Cancer Center (2) · National Cancer Institute (NCI) (2) · Rigshospitalet, Denmark (2) · University of Utah (2) · University of California, San Francisco (1)
Often tested with
Tested in the same studies.
Fluoroestradiol f-18 (2) · Florilglutamic acid f-18 (1) · Sodium fluoride f-18 (1) · 68 Ga-P16-093 (1) · Rubidium (1) · Sunitinib (1) · Cisplatin (1) · Docetaxel (1)
Studies
Open first, then newest update. How each study uses Fluorodeoxyglucose F18 is read from its arms, and is right about nine times in ten.
Testing it · 39
- Imaging Mitochondrial Complex-I in Alcohol Use DisorderRecruitingEarly Phase 1Rajesh NarendranNCT07825818Written as [F-18]FDG
- PET Imaging Study of 68Ga-NB381 in Multiple MyelomaRecruitingEarly Phase 1Peking University First HospitalNCT06385652Written as 68Ga-NB381
- Glucose Consumption in MS Using [F-18]FDG-PETRecruitingPhase 4Brigham and Women's HospitalNCT07087106Written as [F-18]FDG
- Ultralow Dose PET Imaging of 18F-FDG UptakeRecruitingPhase 2Akiva MintzNCT06956391Written as 18F-FDG
- Head-to-head Comparison of Diagnosis Value of Pulmonary Fibrosis on 68Ga-FAPI-04 and 18F-FDG PET-CTRecruitingPhase 1Peking Union Medical College HospitalNCT05121779Written as 18F-FDG
- Clinical Study of 18F-Alfatide Injection PET/CTNot yet recruitingPhase 3Yantai LNC Biotechnology Singapore PTE. LTD.NCT06416852Written as 18F-FDG Injection
- Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer PatientsEnrolling by invitationPhase 2Rigshospitalet, DenmarkNCT05396118Written as 18F-FDG
- Dual 64Cu-DOTATATE and 18F-FDG PET/CT Imaging of Patients With Neuroendocrine NeoplasmsEnrolling by invitationPhase 2Rigshospitalet, DenmarkNCT05709171Written as 18F-FDG
- Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial ImagingRecruitingPhase 1/2University of PennsylvaniaNCT04275453Written as FDG
- Comparison of Whole Body DWI to FDG PETActive, not recruitingNot applicableUniversity of California, San FranciscoNCT06630845Written as Fluorodeoxyglucose F18
- Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot StudyCompletedNot applicableUniversity Health Network, TorontoNCT02678884Written as 18-F FDG
- Determination of Molecular Status, the Efficacy and Safety of Fluorodeoxyglucose in PET-CT ImagingActive, not recruitingPhase 3Anna RaciborskaNCT04943211Written as fluorodeoxyglucose (18F-FDG)
- Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted TherapyActive, not recruitingPhase 2University of WashingtonNCT04692103Written as Fludeoxyglucose F-18
- 18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or TransplantActive, not recruitingPhase 1M.D. Anderson Cancer CenterNCT02379377Written as Fluorine F 18 2-deoxy-2-(18F)fluoro-D-glucose
- Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer PatientsCompletedNot applicableUnion Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNCT07553741Written as 18F-FDG
- Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerTerminatedPhase 1Mayo ClinicNCT03432741Written as Fludeoxyglucose F-18
- Assessment of Primary and Metastatic Brain Tumor Hypoxia With Fluoromisonidazole, FDG and WaterTerminatedPhase 1University of UtahNCT01246869Written as [18F]fluoro-2-deoxy-D-glucose (FDG)
- FDG PET-MRI for the Diagnosis of Spinal Cord LesionsCompletedNot applicableM.D. Anderson Cancer CenterNCT04219969Written as Fludeoxyglucose F-18
- Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal MetastasesCompletedPhase 2Stanford UniversityNCT00375830Written as 18F-Fludeoxyglucose (18F-FDG)
- Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation TherapyCompletedPhase 1Emory UniversityNCT03493789Written as Fludeoxyglucose F-18
See all 39 studies that test Fluorodeoxyglucose F18 →
Given in every arm · 4 — Fluorodeoxyglucose F18 is usual care beside what is tested
- Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy for Stage III Non-small Cell Lung CancerCompletedPhase 2National Cancer Institute (NCI)NCT01507428Written as Fludeoxyglucose F-18
- 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung NodulesCompletedPhase 2Andrei IagaruNCT03824535Written as Fludeoxyglucose F-18
- Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaCompletedEarly Phase 1M.D. Anderson Cancer CenterNCT02405078Written as Fludeoxyglucose F-18
- Molecular Imaging With Erlotinib and BevacizumabCompletedPhase 2University of CologneNCT01047059Written as Fluoro-D-glucose
Codes
What other systems call Fluorodeoxyglucose F18 · ClinicalTrials.gg INT008716
- MeSH (NLM) D019788Fluorodeoxyglucose F18Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) 0Z5B2CJX4DFLUDEOXYGLUCOSE F-18Confirmed FDA, NLM
- RxNorm 1362737One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019788 | Fluorodeoxyglucose F18 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 0Z5B2CJX4D | FLUDEOXYGLUCOSE F-18 | Confirmed FDA, NLM |
| RxNorm | 1362737 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.